Judge gives Trump administration Wednesday night deadline to pay millions in USAID funds
- A federal judge issued a preliminary injunction blocking President Donald Trump's administration from freezing grants and loans potentially totaling trillions of dollars.
- U.S. District Judge Loren AliKhan stated that the administration "cannot pretend that the nationwide chaos and paralysis from two weeks ago is some distant memory with no bearing on this case."
- Plaintiffs presented evidence claiming that the funding freeze would be economically catastrophic to their members.
- The judge ordered the Trump administration to provide millions of dollars to multiple nonprofit groups, stating that it violated a temporary restraining order regarding foreign aid.
126 Articles
126 Articles

How Trump’s $2B court battle over foreign aid could reshape executive authority
A sign outside of the U.S. Agency for International Development building in Washington, D.C. Bryan Dozier/Middle East Images/AFP via Getty Images Amid the chaos of the Trump administration’s first few weeks in office, a court case regarding the president’s legal right to stop payment of nearly $2 billion in U.S. Agency for International Development contracts poses an important legal question whose answer may show just how strong the country’s se…
News24 | Trump administration says it cannot meet court deadline for foreign aid payments
President Donald Trump's administration said in a court filing late Tuesday night that it "cannot" meet a federal judge's 11:59 p.m. Wednesday deadline for releasing frozen funds to foreign aid contractors and grant recipients, potentially
Q&A: How Trump’s USAID freeze halted the effort to develop an effective HIV vaccine in Africa
Last month, researchers in South Africa were preparing to administer two experimental HIV vaccines in a Phase 1 clinical trial. The staff was trained, immunizations were ready, and participant screening had begun. Then, they received a stop-work order: The $45 million in funding from USAID to support the project was frozen under a 90-day review — and could be withdrawn completely. The trial was designed to test novel immunogens identified in Af…
Coverage Details
Bias Distribution
- 39% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage